Pharma Marketing News
PMN Home | Advertising Information | FAQs
About Us | Contact Us | Privacy Policy
Subscribe Glossary
Pharma Marketing Blog Pharmaguy Audio Podcasts Conference Calendar Reader Surveys

Share |

Pharmaguy's Insights Into Drug Industry News
Pharmaguy's Insights Into Drug Industry News
www.pharmaguyinsights.com

"I trust Pharmaguy to cut through the clutter and pick the news I need to see. Adding his insights just ices the cake as far as I'm concerned." - anonymous reader

Vol. 13, Issue No. 10: December 2014 - EXECUTIVE SUMMARY

Are Drug.com Websites "Fair and Balanced?"
FDA Studies Online DTC Prescription Drug Promotion

Fair and Balanced Drug.comAccording to Internet analytics provider comScore, patients who visit a drug brand's website are more likely to end up taking that drug than those who don't. FDA is aware of this and cited a Prevention Magazine 2011 survey that found that 49 percent of respondents who went online for prescription drug information reported seeking this information on a specific brand's Web site.

As a consequence of this influence of the Internet, FDA is currently studying how consumers interact with drug.com websites. Specifically, according to an April, 2011, public notice, FDA has a number of questions surrounding how to achieve "fair balance" in online DTC promotion.

This article reviews the study "Examination of Online Direct-to-Consumer Prescription Drug Promotion" (FDA-2011-N-0230), which is designed to test different ways of presenting prescription drug risk and benefit information on branded drug Web sites.

Topics include (partial list):
  • Is FDA Out of Touch?
  • Format & Visibility of ISI
  • Table: Recent Rx Drug Advertising Studies proposed by FDA
  • What About Online Testimonials?
  • To Link or Not To Link?
  • Impact on Internet Guidance
The full version of this article is available to subscribers. Subscription is free.

Pharma Marketing News Email Addr:  

FDA To Study DTC Promotion Directed at Adolescents
Focus is on Immediate Benefits vs. Deferred Risks

The Adolescent Brain"Adolescents are a unique audience for DTC drug marketing because their cognitive abilities are different than those of adults," noted the FDA in an October, 2013, Federal Register notice to conduct an "Experimental Study of Direct-to-Consumer Promotion Directed at Adolescents" (FR # FDA-2013-N-1151). Yet some pharmaceutical companies are promoting powerful drugs to teens on the Web and on TV.

FDA's proposed study will have adolescents and their parents view a DTC promotional campaign for either a fictitious Attention Deficit Hyperactivity Disorder (ADHD) medication or a fictitious acne medication. The study will explore similarities and differences in perceptions for these matched pairs. This article is a review of that study, which aims to assess how adolescents interpret drug risk in DTC advertising.

Topics include (partial list):
  • Examples of Drugs Marketed to Teens
  • FDA's Research Into Teen-Targeted DTC Ads
  • The Adolescent Brain
  • Shire's Comments
The full version of this article is available to subscribers. Subscription is free.

Pharma Marketing News Email Addr:  

Does Your Spouse Influence Your DTC Viewing Experience?
FDA Wants to Peek Into Your Bedroom

Spousal InfluenceFDA's Office of Prescription Drug Promotion (OPDP) plans to examine differences between consumers viewing prescription drug ads with a spouse versus alone.

In its Federal Register notice about the "Spousal Influence" study ("Spousal Influence on Consumer Understanding of and Response to Direct-To-Consumer Prescription Drug Advertisements"; FDA-2014-N-1819), FDA presented this premise:

"Judgments about prescription drugs portrayed in DTC ads are likely made in social contexts much of the time. For example, a potential consumer and his or her spouse (e.g., marital or domestic partner) may view an ad together and discuss drug benefits, side effects, and risks. These social interactions may result in unique reactions relative to consumers who view DTC prescription drug ads alone."

This article is a review of that study.

Topics include (partial list):
  • Study Design
  • A Missed Opportunity
  • Impact on Regulation of Ads
  • A Viagra Ad Your Spouse May Not Want You to See
The full version of this article is available to subscribers. Subscription is free.

Pharma Marketing News Email Addr:  

Vol 13, #10 Contents






Messages from Our Sponsors

Pharma Marketing News Email Addr:  

Contact Information
Editor
Pharma Marketing News

Pharma Marketing News | Subscribe | Industry Insights | Podcasts | Pharmaguy | Blog
Surveys | Glossary | Conference Calendar | Advertising Information | FAQs | About Us | Privacy Policy

© 2014. Pharma Marketing Network. All rights reserved.